Assessing Abbott Laboratories (ABT) Valuation After Recent Share Price Weakness [Yahoo! Finance]
Abbott Laboratories (ABT)
Last abbott laboratories earnings: 4/16 07:30 am
Check Earnings Report
US:NYSE Investor Relations:
abbott.com/investors.html
Company Research
Source: Yahoo! Finance
Abbott Laboratories (ABT) has drawn investor attention after a weak share price patch, with the stock down about 7% over the past month and 20% over the past 3 months. At a last close of US$101.83 and a market value near US$178.2b, Abbott sits on annual revenue of about US$44.3b and net income of roughly US$6.5b across its diversified healthcare segments. See our latest analysis for Abbott Laboratories. Recent trading shows momentum fading, with the 30 day share price return around 7% lower and the year to date share price return down about 18%, while the 1 year total shareholder return is roughly 16% lower. This points to a softer near term tone after a modestly positive 3 year total shareholder return. If recent weakness in large healthcare names has you reassessing your watchlist, this can be a useful moment to size up opportunities in 37 healthcare AI stocks With Abbott trading around US$101.83 and reporting roughly US$44.3b in revenue and US$6.5b in net income, the key
Show less
Read more
Impact Snapshot
Event Time:
ABT
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
ABT alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
ABT alerts
High impacting Abbott Laboratories news events
Weekly update
A roundup of the hottest topics
ABT
News
- New survey finds most Americans believe chronic diseases are preventable, but only 1 in 4 feel confident in how to care for their health [Yahoo! Finance]Yahoo! Finance
- New survey finds most Americans believe chronic diseases are preventable, but only 1 in 4 feel confident in how to care for their health [TheStreet.com]TheStreet.com
- New survey finds most Americans believe chronic diseases are preventable, but only 1 in 4 feel confident in how to care for their healthPR Newswire
- Abbott Laboratories (ABT) had its price target raised by Barclays PLC from $142.00 to $144.00. They now have an "overweight" rating on the stock.MarketBeat
- Abbott Laboratories (ABT) had its price target lowered by The Goldman Sachs Group, Inc. from $140.00 to $121.00. They now have a "buy" rating on the stock.MarketBeat
ABT
Earnings
- 1/22/26 - In-Line
ABT
Sec Filings
- 4/2/26 - Form 4
- 4/2/26 - Form 4
- 4/2/26 - Form 4
- ABT's page on the SEC website